Medtronic (MDT) PT Raised to $90 at Jefferies on 'Very Good' Q3
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Medtronic (MDT) PT Lifted to $90 at Piper Jaffray Post Q3
February 18, 2015 7:44 AM ESTPiper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Medtronic, Inc. (NYSE: MDT) to $90.00 (from $83.00) following Q3 results.
West commented, "Medtronic reported F3Q15 results, the last before reporting as combined Medtronic/ Covidien, with revenues of $4.318B (+8%cc) easily beating... More
Medtronic (MDT) Reports Q3 EPS of $1.04
February 17, 2015 7:16 AM ESTMedtronic (NYSE: MDT) reported Q3 EPS of $1.04, may not compare to the analyst estimate of $0.97. Revenue for the quarter came in at $4.32 billion versus the consensus estimate of $4.25 billion.
For earnings history and earnings-related data on Medtronic (MDT) click here.
... MoreMedtronic (MDT) Receives CE Mark for Euphora Semicompliant Balloon Catheter
February 17, 2015 6:26 AM ESTMedtronic (NYSE: MDT) announced the launch of the Euphora Semicompliant Balloon Dilatation Catheter in countries that recognize the CE (Conformité Européene) mark. The first patient case with the Euphora Semicompliant Balloon Catheter was recently performed by Richard Edwards, M.D., consultant cardiologist at the Freeman Hospital in Newcastle, United Kingdom. It is not available in the United States.
"After performing the first patient case with Euphora, it is the most deliverable balloon catheter I have used," said Dr. Edwards. "The exceptionally low crossing profile and pushability make... More
Medtronic (MDT) Receives FDA Clearance of VERTEX Reconstruction System
February 17, 2015 6:25 AM ESTMedtronic (NYSE: MDT) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for expanded indications of the VERTEX Reconstruction System. The new clearance for the VERTEX family of products allows for lateral mass and pedicle screws to be used as a form of fixation to treat various pathologies occurring in the posterior cervical spine, making it one of the first FDA-cleared systems available in the United States for use of screws at C1-C7.
"Broadening the... More
